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Abstract
Background: Resistant glucan (RG) and hydrogenated resistant glucan (HRG) are new dietary fiber materials
developed to decrease the risk of metabolic syndrome and lifestyle-related diseases. We investigated the
metabolism and bioavailability of RG and HRG using rats and humans.
Methods: Purified RG and HRG were used as test substances. After 25 Wistar male rats (270 g) were fed with an
experimental diet (AIN93M diet with the cellulose replaced by β-corn starch) ad libitum for 1 week, they were used for
the experiment involving blood collection and circulating air collection. Ten participants (5 males, 22.5 y, BMI 20.4 kg/
m2; 5 females, 25.8 y, BMI 20.9 kg/m2) voluntarily participated in this study. The study was carried out using a
within-subject, repeated measures design. Effects of RG and HRG on the response for blood glucose and insulin and
hydrogen excretion were compared with those of glucose and a typical nondigestible and fermentable
fructooligosaccharide (FOS) in rats and humans. Available energy was evaluated using the fermentability based on
breath hydrogen excretion.
Results: When purified RG or HRG (400 mg) was administered orally to rats, blood glucose and insulin increased
slightly, but less than when glucose was administration (P < 0.05). Hydrogen started to be excreted 120 min after
administration of RG with negligibly small peak at 180 min, thereafter excreted scarcely until 1440 min. Hydrogen
excretion after HRG administration showed a larger peak than RG at 180 min, but was markedly less than FOS. RG and
HRG were excreted in feces, but not urine. When purified RG or HRG (30 g) were ingested by healthy humans, blood
glucose and insulin levels increased scarcely. Breath hydrogen excretion increased slightly, but remarkably less than
FOS. Ingestion of purified RG or HRG (5 g) to evaluate available energy, increased scarcely glucose and insulin levels
and breath hydrogen excretion. Available energy was evaluated as 0 kcal/g for purified RG and 1 kcal/g for HRG.
Conclusion: The bioavailability was very low in both humans and rats, because oligosaccharide of minor component
in purified RG and HRG was metabolized via intestinal microbes but major components with higher molecular weight
were metabolized scarcely. Moreover, the ingestion of 30 g of RG or HRG did not induce apparent acute side effects in
healthy adults. RG and HRG might potentially be used as new dietary fiber materials with low energy.
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Background
Resistant glucan (RG) and hydrogenated resistant glucan
(HRG) are new dietary fiber materials that have been de-
veloped to decrease the risk of metabolic syndrome and
lifestyle-related diseases. RG is prepared by heating glu-
cose at 180 °C in the presence of activated carbon [1],
and is a mixture of monosaccharides, oligosaccharides
and glucose polymers with an average molecular weight
of approximately 2600. RG is a white odourless powder
that is easily dissolved in cold water and can be widely
used as a low energy bulking carbohydrate material.
HRG is produced from RG by hydrogenation, and is
more stable than RG toward degradation by the Maillard
reaction [1].
In order to use widely RG and HRG as food materials,
it is necessary to clarify the physiological effects of RG
and HRG on the response for blood glucose and insulin,
the occurrence of abdominal symptoms, the maximum
non-effective dose for osmotic diarrhea, fermentability
by intestinal microbes and metabolic fate. In addition,
the available energy including nondigestible carbohy-
drates must be expressed as nutritional labeling in proc-
essed foods based on the Law of some countries [2, 3].
We have already proposed the indirect and simple
method to evaluate the available energy of dietary fiber
materials in healthy humans [4–6]. In accordance with
our method, the digestibility is estimated based on the
response of blood glucose and insulin and the ferment-
ability is estimated by breath hydrogen excretion. In the
present study, the metabolism and bioavailability of RG
and HRG were investigated using rats and healthy hu-
man subjects and the available energy for purified RG
and HRG was estimated by our proposed method.
In a previous study [7], it has been demonstrated that
purified RG and HRG were consist of small amounts of
glucose and digestible and fermentable oligosaccharides,
and large amounts of nondigestible glucose polymers
with high molecular weight. Purified RG and HRG are
hydrolyzed to a limited extent by digestive enzymes, and
did not inhibit small intestinal disaccharidases such as
sucrase and maltase. These results agree roughly with
the dietary fiber content of purified RG (99 %) and HRG
(82 %), which have been measured by the enzymatic-high
performance liquid chromatography (HPLC) method of
the Association of Official Analytical Chemists (AOAC)
2001.03 method [8].
In rats, the ingestion of a diet containing 5 % of purified
RG or HRG caused loose stools in consecutive feeding ex-
periments. However, the growth and development of the
rats were normal and no specific abnormal observations
in the tissues and organs were inspected, except for a not-
able increase in the weight of cecal tissue and content. In
addition, blood biochemical parameters such as glucose,
insulin, total cholesterol, free fatty acid, total protein, AST
and ALT etc. were normal in the RG, HRG, resistant
maltodexitrin (RMD), fructoologosaccharide (FOS) and
control groups and they were not significantly different
among the five groups [7]. Furthermore, the abnormality
is not detected in acute, subacute and chronic toxicity
tests of RG [9]. Also, RG and HRG have been confirmed
in the earlier work on the safety and stability of RG [1].
Therefore, RG and HRG seem to be safety as nondigesti-
ble carbohydrate materials.
RMD and polydextrose (PD) have been widely used in
the processed foods and the health claim for its use in
processed foods is potentially reduce the energy density
[10–14]. The available energy is evaluated as 1 kcal/g for
RMD and PD based on our proposed method [5]. Also,
Auerbach, et al. [12] and Goda, et al. [14] report that the
available energy is estimated as 1 kcal/g each for RMD
and PD using different methods. The results obtained
from in vitro and in vivo experiments for RG and HRG
demonstrate that RG and HRG are notably resistant to
hydrolysis by human α-amylase and small intestinal
enzymes and are difficult to be fermented by intestinal
microbes compared with RMD and PD [7]. Therefore,
we hypothesize that the available energy of purified RG
and HRG is less or at least the same than quality
obtained from RMD and PD.
In the present study, prior to the human study, we
performed a study using rats to investigate some physio-
logical effects such as the response indicated by blood
glucose and insulin, hydrogen excretion, and fecal and
urinary excretion after single dose of the tested sub-
stances. Then, we carried out human experiments using
a within-subject repeated measures design. The response
of blood glucose and insulin, breath hydrogen excretion,
the occurrence of abdominal symptoms, and fecal shape
were investigated using healthy human subjects. In
addition, the available energy of purified RG and HRG
for human subjects was evaluated by an indirect and
simple method based on fermentability using breath
hydrogen excretion [4–6, 15, 16]. The results obtained
will contribute to the practical application of RG and
HRG for potentially decreasing the risk of metabolic
syndrome and lifestyle-related diseases.
Methods
Ethical approval of the study protocol
All experiments complied with the code of ethics of the
World Medical Association (Declaration of Helsinki, Oct.
2013). The study protocol involving human subjects was
approved by the Ethical Committee of the University of
Nagasaki (received No.184, approval No.177). All partici-
pants provided written informed consent to participate in
the study.
The protocol for animal studies was approved by
(approved No. 2011-15) the Committee on Animal
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Experiments of the University of Nagasaki. These
experiments were conducted according to the Guide-
lines on the Care and Use of Laboratory Animals
(National Institutes of Health, MD, USA) and the
standards relating to the Care and Management of
Experimental Animals (Notification number 88, from
the Prime Minister’s Office). All experiments were
carried out in the Public Health Nutrition Laboratory
of the Graduate School of Human Health Science,
University of Nagasaki Siebold.
Materials
Purified RG (Nihon Shokuhin Kako Co., Ltd., Tokyo,
Japan) by removing mono- and di-saccharides from RG,
was used to focus for the main components with degrees
of polymerization (DP) of more than 2 in the present
study, and HRG (Nihon Shokuhin Kako Co., Ltd.) was
also used to compare with purified RG. RMD (Fibersol-2,
dietary fiber content: 92 %, Matsutani Chemical Industry
Co., Ltd., Hyogo, Japan), FOS (purity: > 99 %, Meiji Co.,
Ltd., formerly-Meiji Seika Kaisha Ltd., Tokyo, Japan) and
glucose (Nihon Shokuhin Kako Co., Ltd.) were also used
in the present study. Glucose was used as a reference of
the response of blood glucose and insulin. RMD is a mix-
ture of monosaccharides, oligosaccharides and glucose
polymers with an average molecular weight of about 2000
[10, 11]. It was used as a reference of dietary fiber estab-
lished already. FOS was used as a reference of a typical
oligosaccharide that is not hydrolyzed by digestive en-
zymes and is fermented completely by intestinal microbes
[17, 18] and consists of 1-kestose (39 %), nystose (53 %),
and 1F-β-fructofranosyl-nystose (7 %).
Animal experiments using rats
Animals and diets
To investigate the effect of RG and HRG on the response
of blood glucose and insulin and the fermentability of RG
and HRG by intestinal microbes, 25 Wistar male rats
(270 g, Clea Japan Inc., Tokyo, Japan) as the previous
studies [7, 17], were fed with an experimental diet ad libi-
tum or 1 week. They were used twice: for the experiment
involving blood collection and the experiment involving
circulating air collection. The experimental diet was
AIN93M diet [19] with the cellulose replaced by β-corn
starch to exclude the effect of cellulose on the intestinal
microflora. Rats were housed in individual stainless steel
cages and kept at room temperature (22–24 °C). The rela-
tive humidity was maintained at 50–55 % with a 12-h
light/dark cycle.
Experimental setup for determination of plasma glucose
and insulin responses
The effects of glucose, RG, HRG and RMD on the re-
sponse of blood glucose and insulin were investigated.
Glucose was used as a control and RMD was used as a
positive control, as it has been established previously as
a dietary fiber material. The dose (400 mg) of test sub-
stance which does not cause loose stool in rat was dis-
solved in 2.5 ml of distilled water as the previous studies
[18, 20]. The test solution was orally administered to a
rat using a stomach tube after fasting for 16 h (n = 5 per
group). Blood (120 μl) was collected from the rat’s tail
vein using heparinized hematocrit tubes at 30-min inter-
vals until 180 min after administration of the test sub-
stance, and then the plasma was prepared by hematocrit
centrifugation (3300, Kubota Co., Ltd., Tokyo, Japan) at
2000 × g, 20 °C for 5 min.
Glucose concentration was measured by the Trinder
method using glucose oxidase [21]. After plasma (10 μl)
was pipetted into a small test tube, glucose oxidase
reagent (1.5 ml) was added and the test tube was incu-
bated at 37 °C for 15 min. Then the test tube was
steeped in boiling water for 150 s to stop the reaction.
The absorbance was read immediately using a spectro-
photometer (UVmini-1240, Shimadzu Corp., Kyoto,
Japan) at a wavelength of 505 nm. The insulin concen-
tration was measured immunologically by an ELISA kit
(Morinaga Biochemical Institute Co., Kanagawa, Japan)
using guinea pig-derived antibody [22].
Circulating air collection and analysis of hydrogen
The effects of FOS, RG, HRG and RMD on hydrogen
excretion were also investigated using rats. FOS was
used as a reference of typical nondigestible and ferment-
able oligosaccharide to compare fermentability. Each test
solution was prepared as 400 mg in 2.5 ml distilled
water. Five rats fed with the experimental diet and 15
rats fed with the experimental diet for 2 days after blood
collection, were used in the experiment involving circu-
lating air collection. Fifteen rats which had been used in
the experiment of blood collection were administered
with same test solution as the experiment of blood col-
lection and five new rats were administered with FOS
solution. The test solution (400 mg/2.5 ml) was orally
administered to a rat (n = 5 per group) after fasting for
16 h. Then the rats were immediately moved to the
Metabolica apparatus (5-gang, Sugiyamagen Co., Ltd.,
Tokyo, Japan) (Fig. 1) to collect the circulating air for
hydrogen determination.
The flow rate of the circulating air in the apparatus was
adjusted to 200 ± 30 ml/min. To obtain the initial value,
40 ml of circulating air was collected using a plastic syr-
inge at 10 min after moving the rat into the apparatus.
Then the circulating air was collected at 1-h intervals until
4 h, 2-h intervals from 4 h to 10 h, and at 24 h after ad-
ministration of the test solution [23]. To avoid hunger, the
experimental diet was fed to the rats at 4 h after adminis-
tration of test solution. Five millilitres of the circulating
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air were loaded into a simple gas chromatograph (Breath
Gas Analyzer BGA1000D, Laboratory for Expiration
Biochemistry Nourishment Metabolism Co., Ltd., Nara,
Japan) to measure the concentration of hydrogen.
Extraction of RG and HRG from feces and urine and
analysis by HPLC
After RG or HRG (400 mg/2.5 ml) was orally adminis-
tered to the rats, their urine and feces were collected
separately using the Metabolica apparatus for 24 h. The
collected feces were combined, stood for 10 min in boil-
ing water to stop the reaction by microbes-derived
enzymes and homogenized with 9 volumes of ice-cold
0.9 % NaCl using a homogenizer (Polytron; Kinematica
Inc., Lucerne, Switzerland). Then the suspension was cen-
trifuged under refrigeration (Himac CR22GII, Hitachikoki
Co., Ltd., Tokyo, Japan) at 20,000 × g, 4 °C for 20 min. The
precipitate was re-suspended with 4 volumes of 0.9 %
NaCl and centrifuged again. The supernatants collected
were combined and filtered through a membrane filter
(0.22 μm× 13 mm; Millipore Corp., MA, USA) to remove
bacteria and small pellets, then used in the HPLC analysis.
The urine collected was measured the volume, and then
was also filtered through a membrane filter (0.22 μm×
13 mm) to remove bacteria and small pellets.
The analysis of RG and HRG was carried out using an
HPLC system (LC-20 AD; Shimadzu Corp.) using a re-
fractive index detector (RID-10A; Shimadzu Corp.) and
a Shodex SUGAR KS-802 column (8.0 φ × 300 mm;
Showa Denko Co., Ltd., Tokyo, Japan). Analysis was per-
formed at a column temperature of 70 °C. The sample
(10 μl) was injected into the HPLC system and eluted
with deionized distilled water at a flow rate of 0.5 ml/
min [24]. The limit concentration of detection of glucose
by HPLC analysis was 10 μg/ml.
Human experiments using healthy subjects
Participants
The present study involving human participants was
carried out using a within-subject, repeated measures
design. Each subject ingested repeatedly the test sub-
stance at intervals of 1-week or more. Ten healthy par-
ticipants (5 males, 22.5 ± 1.7 year old, 59.7 ± 2.5 kg, BMI
20.4 ± 1.2 kg/m2; 5 females, 25.8 ± 3.8 year old, 50.5 ±
4.0 kg, BMI 20.9 ± 1.1 kg/m2) voluntarily participated in
this study. The exclusion criteria were a history of
gastrointestinal diseases, carbohydrate malabsorption, dia-
betes, obesity or pulmonary disease. The average value of
fasting blood glucose concentration of the subjects was
4.6 ± 0.2 mmol/L and it was within normal range. Before
the experiments, we ensured that all participants were
hydrogen producers and not methane producers. The par-
ticipants had not taken any antibiotics or laxatives in the
2 weeks before the experiments.
Preparation of test solutions
The effects of glucose, FOS, RG and HRG on blood glu-
cose and insulin response and breath hydrogen excretion
were investigated. Glucose was used as a control and
FOS was used as a typical nondigestible and fermentable
oligosaccharide. Thirty grams of glucose, RG or HRG
were dissolved in 120 ml of warmed safety water as the
previous studies [4, 5, 25–28]. The tolerance level of
FOS, because of its osmotic effects in the large bowel,
Fig. 1 Metabolica apparatus to collect the circulating air, urine and faeces of rats
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is 0.3 g/kg of body weight for Japanese normal people
[6, 25]. Therefore, 5 g of FOS was dissolved in 120 ml of
warmed safety water in accordance with our proposed
method [4, 5, 25]. Five grams of RG or HRG were also
dissolved in 120 ml of warmed safety water to evaluate
available energy.
Special meals for experiments
The period during which the food intake of the subjects
was restricted was very long. Hence, the experimental
meals, from which hydrogen was not produced, were
given to the subjects after the final blood collection, at
7 h and 11 h after ingestion of test substance. Canned
tuna fish (Sea-chicken mild, 80 g, Hagoromo Food Co.,
Ltd., Shizuoka, Japan), boiled egg (50 g) and tea contain-
ing 10 g of table sugar were used as food materials for
experimental meals. The energy supplied to the subjects
on the experimental day was 895 ~ 970 kcal and protein
was 58 ~ 65 g. If needed, tea containing sugars or boiled
egg was given. In addition, each subject was given a
multivitamin tablet containing mineral (Nature Made,
Otsuka Pharmaceutical Co., Ltd., Tokyo, Japan) as a sup-
plement every day during the experimental periods.
Experimental protocol
All test substances were given in a random order at inter-
vals of 1-week or more. Experiments were carried out
under the direction of a physician. The experimental
protocol was carried out in accordance with the methods
employed in our previous studies [4–6, 25–29].
After overnight fasting, the subjects came to our la-
boratory in the morning, their health status was exam-
ined and their blood pressure and pulse rate were
measured. Then, 750 ml of end-expiratory gas were col-
lected using a collection bag (Quin Tron Instrument
Co., Inc., WI, USA) and 120 μl of blood from the finger-
tip using a heparinized hematocrit tube. After ingesting
the test substance, the end-expiratory gas was collected
at 1-h intervals until 14 h [4], and blood (120 μl) was
collected at 30-min intervals until 180 min. Participants
were prohibited from ingesting foods containing nondi-
gestible carbohydrates for 3 days before each experimental
day. During the experiment, they were also prohibited
from ingesting foods or beverages except for warmed
water and tea, as well as from sleeping and smoking. Sub-
jects were required to sit on a chair and were prohibited
from exercising with hyperventilation until the final
collection of end-respiratory gas. Participants ingested an
experimental meal that did not produce breath hydrogen,
so that they would not feel hungry.
After ingesting the test substance, the type and onset
time of abdominal symptoms, the frequency of defecation
and the macroscopic observation of stool shape were re-
corded by the participants themselves using constructed
format. The research supervisor explained to all partici-
pants the method for self-recording and classifying the
stool shape and abdominal symptoms, and then confirmed
their recordings, when they were received. The examin-
ation of stools used the following descriptors: stage 1, very
hard; stage 2, hard; stage 3, normal; stage 4, soft; stage 5,
very soft; and stage 6, watery [30]. The questionnaire on
abdominal symptoms were asked to the subjects about
their experience of upper and lower abdominal pain,
vomiting, nausea, thirst, flatus, distension, and borboryg-
mus for 14 h after ingesting the test substance.
Assay of plasma glucose and insulin and analysis of
breath hydrogen
The plasma glucose and insulin concentrations and
hydrogen in the end-expiratory gas were measured by
the methods described above.
Evaluation of relative available energy of RG and HRG
An indication of energy content is an essential item for
the nutritional labelling of processed foods [2, 3]. The
available energy in dietary fiber materials and nondiges-
tible oligosaccharides can be evaluated using an indirect
and simple method based on the breath hydrogen excre-
tion which reflects the fermentability of nondigestible
carbohydrate [4–6, 25]. As energy production is dependent
on the fermentability of nondigestible carbohydrates, the
available energy can be categorized to 0 kcal/g, 1 kcal/g
and 2 kcal/g. Available energy was calculated based on the
ratio of fermentability versus FOS, which has 2 kcal/g of
available energy, in the present study [15, 16].
To evaluate the available energy of RG and HRG using
the indirect and simple method based on fermentability,
5 g of the test substance were ingested by a healthy
subject as well as other dietary fiber materials. The end-
respiratory gas was collected to measure hydrogen
excretion for 14 h after ingestion. FOS (2 kcal/g) was
used as a convenient reference to estimate the relative
fermentability [4, 5, 25].
Calculations and Statistical analyses
We calculated the means and standard deviations in blood
glucose, insulin and concentration of hydrogen excretion
in rats and humans. Evaluation of the available energy in
humans was calculated based on the ratio [4, 5]. The ratio
was calculated based on the areas under the curve (AUC)
of hydrogen excretion by the ingestion of test materials
versus that of FOS. Thereafter, the available energy was
classified into 0 kcal/g, 1 kcal/g and 2 kcal/g as described
above. The normal distribution was tested, and the data
with normal distribution were compared with control (ref-
erence) using ANOVA and Dunnett’s post hoc test or
Tukey’s post hoc test, and non-normal distribution data
were compared using non-parametric analysis by Steel or
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Steel-Dwass method. A P-value less than 0.05 obtained
two-sided analysis was considered as significant using
SPSS for Windows 20.0 (SPSS Inc., Tokyo, Japan).
Results
Animal experiments using rats
The effects of RG and HRG administration on blood glucose
and insulin levels
The plasma glucose and insulin concentrations increased
spontaneously at 30 min after glucose (400 mg/2.5 ml)
was administered orally to rats (Fig. 2a, b). The results
show that the response of blood glucose and insulin is
normal in rats. For RG administration, the plasma glu-
cose level increased to 5.6 mmol/L and plasma insulin
level reached at more than 450 pg/mL at 30 min after
administration. The response of plasma glucose and in-
sulin after administration of HRG and RMD was similar
to that of RG and not significantly different among three
test substances. Moreover, the response of plasma glu-
cose and insulin after administration of RG, HRG and
RMD were significantly lower than those of the adminis-
tration of glucose (P < 0.05). These results suggest that
when RG and HRG are given orally to rats, they are par-
tially hydrolyzed by gastrointestinal enzymes and cause
similar increases in blood glucose and insulin levels.
The effects of RG and HRG administration on hydrogen
excretion
We considered that the excretion profile of hydrogen
was normal, because when FOS (400 mg/2.5 ml) was
given to rats, hydrogen which is produced only through
fermentation by intestinal microbes, started to excrete
about 120 min after administration and reached the
maximum (80 ppm) at 480 min (8 h) (Fig. 3). For puri-
fied RG (400 mg/2.5 ml), hydrogen was excreted less
than 10 ppm about 120 min after administration and
then decreased to the basal level at 360 min. Hydrogen
excretion after HRG administration (400 mg/2.5 ml)
exhibited a similar behaviour to that of RG and was
not significantly different. Hydrogen excretions of RG
and HRG were significantly lower than that of FOS
(P < 0.05). Hydrogen excretion after RMD administra-
tion showed a different pattern from that of RG and
HRG, and it was significantly lower compared with
that of FOS (P < 0.05).
Urinary and fecal excretion of RG and HRG administered
to rats fed with control diet
After RG or HRG (400 mg/2.5 ml) was orally adminis-
tered to rats fed with the experimental diet, urine and
feces were separately collected with the Metabolica ap-
paratus for 24 h. Neither RG nor HRG were detected in
the urine, but 20.4 % of the RG and 23.2 % of the HRG
administered were excreted into feces for 24 h.
Human experiments using healthy subjects
Subject participation
No participants dropped out of the study and experi-
enced side effects. Their health status throughout the
entire study period was well. The average intake of
energy by a participant was 935 kcal/day and that of
protein was 61 g/day.
The effects of ingestion of RG and HRG on blood glucose
and insulin levels and breath hydrogen excretion
Figure 4 shows the changes in blood glucose and insulin
levels after the ingestion of 30 g of glucose, purified RG
or HRG by healthy participants. As the incremental blood
glucose concentration was approximately 3.1 mmol/L at
30 min after the ingestion of glucose, the participants were
a b
Fig. 2 Changes of blood glucose and insulin levels after oral administration of RG, HRG or RMD to rats fed with an experimental diet. RG,
resistant glucan; HRG, hydrogenated resistant glucan; RMD, resistant maltodextrin. Test substance (400 mg/2.5 ml) was administered orally to each
rat which was fed with an experimental diet (n = 5 per group) and blood was collected from the tail vein at indicated periods. Values were
means ± SD. *,#, The elevation of glucose in RG, HRG, and RMD were significantly lower than that of glucose at each time point, at P < 0.05 by
Dunnett’s post hoc test. There was no significantly difference among RG, HRG, and RMD by Tukey’s post hoc test
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normally tolerant of glucose. After ingestion of RG or
HRG, both the blood glucose and insulin concentrations
showed no incremental response. Blood glucose and
insulin concentrations in RG ingestion were signifi-
cantly lower than that of glucose administration at
30 min after ingestion (P < 0.05). Also, blood glucose
and insulin concentrations in HRG ingestion were
distinctly lower than that of glucose administration at
30 min as well as RG. These results which blood glucose
and insulin concentrations increase scarcely after inges-
tion of RG or HRG are distinctly different from the results
observed in rats.
The participants enrolled in the present study, were
normal responders to breath gas test. When FOS (5 g),
which is not digested by intestinal enzymes and is com-
pletely fermented by intestinal microbes, was ingested by
healthy participants, no increasing on blood glucose and
insulin concentration was observed (data not shown).
The breath hydrogen started to excrete at 3 h after
ingestion and showed a peak (23 ± 9 ppm) at 6 h after
administration (Fig. 5a). Thereafter, it decreased grad-
ually, but continued to excrete over 14 h until the end of
the experiment. In the ingestion of purified RG (30 g),
breath hydrogen started to excrete slightly at 1 h after
ingestion, and then showed a flat without a clear peak
during 2-4 h after ingestion. Thereafter, hydrogen was ex-
creted scarcely up to the end of the experiment (Fig. 5a).
Although breath hydrogen from ingesting HRG (30 g)
Fig. 3 Changes of hydrogen excretion after oral administration of RG HRG or RMD to rats fed with an experimental diet. FOS,
fructooligosaccharide; RG, resistant glucan; HRG, hydrogenated resistant glucan; RMD, resistant maltodextrin. Immediately after test substance
(400 mg/2.5 ml) was orally administered to each rat fed with an experimental diet (n = 5 per group), rats were moved to the Metabolica
apparatus to collect circulating air. Values were means ± SD. *, The excretion of hydrogen was significantly lower in RG, HRG and RMD than in FOS
at each peak point, at P < 0.05 by Steel method. There was no significant difference among RG, HRG, and RMD by Steel-Dwass method
a b
Fig. 4 Change of plasma glucose and insulin levels after ingestion of RG or HRG in healthy human subjects. RG, resistant glucan; HRG,
hydrogenated resistant glucan. After overnight fasting, 30 g of test substance (glucose, Purified RG and HRG) were ingested by 10 healthy
subjects and blood (120 μl) was collected from the tip of finger at 30 min-intervals for 180 min after ingestion. Values were means ± SD. *, #,
Plasma glucose (a) and insulin (b) concentrations in RG or HRG administration were significantly lower than those in glucose administration at
each peak point, at P < 0.05 by Dunnett’s post hoc test for glucose (a) and by Steel method for insulin (b)
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started to excrete clearly about 2 h later than that from
RG, but it was not significantly different.
In the experiments to evaluate the available energy,
hydrogen excretion after ingesting of RG (5 g) did not
increase and showed a flat during the experiment. Also,
hydrogen excretion after HRG ingestion (5 g) was less
than 5 ppm at 3 h after ingestion and were markedly
smaller compared with a peak value (23 ppm) at 6 h
after FOS ingestion (P < 0.05) (Fig. 5b). Namely, hydro-
gen excretion after ingestion of RH or HRG (5 g) was
very little and did not show a significant increment.
Table 1 shows a comparison of the AUC from the
excretion curves of breath hydrogen for 14 h after inges-
tion of the test substances (5 g or 30 g). Although breath
hydrogen excretion was not 0 ppm at 0 min after ingestion
(5 g) of FOS, RG or HRG, the AUC from the curve of
breath hydrogen excretion for 14 h after ingestion was cal-
culated simply. AUC versus time (14 h) was 850 ppm after
purified RG (5 g) ingestion, 1250 ppm after HRG (5 g) in-
gestion and 11,740 ppm after FOS (5 g) ingestion. AUC
versus time (14 h) of high level dose (30 g) was 1320 ppm
for purified RG and 3150 ppm for HRG, respectively, and
the AUC values were clearly larger than that of lower level
dose.
Evaluation trial of available energy of RG and HRG
To evaluate the available energy, 5 g of purified RG
or HRG were ingested by healthy participants as well
as the evaluation of other dietary fiber materials [4–6].
Blood glucose and insulin concentrations did not in-
crease overall and breath hydrogen excretion was neg-
ligible after purified RG ingestion and increased very
slightly after HRG ingestion (Fig. 5b). The AUC from
the curve of breath hydrogen excretion for 14 h after in-
gestion was 11,740 ppm for FOS ingestion, 850 ppm for
purified RG ingestion and 1250 ppm for HRG ingestion
(Table 1). Based on the available energy of FOS is
2 kcal/g, that of RG was evaluated as 0.14 kcal/g (850 ÷
11,740 × 2 = 0.14) and that of HRG was evaluated as
0.21 kcal/g (1250 ÷ 11,740 × 2 = 0.21). The content of diet-
ary fiber, which is resistant for hydrolyzing enzymes in
AOAC 2001.03 method, are 99 % for purified RG and
82 % for HRG, respectively. Thus, the content of di-
gestible saccharide, which the available energy is
4 kcal/g, is 1 % (0.04 kcal/g) for purified RG and
18 % (0.72 kcal/g) for HRG. Therefore, the total avail-
able energy becomes to 0.18 kcal/g (0.14 + 0.04 = 0.18)
for purified RG and 0.93 kcal/g (0.21 + 0.72 = 0.93) for
HRG, respectively. Because numerical values to two
Table 1 Estimation of available energy of RG and HRG in healthy human
Nondigestable fractions Digestable fractions Estimated available
energy (kcal/g)
AUC (ppm/14 h) Ratio versus AUC of FOS (%) Calculated energy (kcal/g) Content (%) Calculated energy (kcal/g) Calculated actual
(1) (2) (1) + (2)
FOS 10,200 (7,800–15,855) 100.0 2 2
RG 601 (120–1,151) 6.1 0.12 1 0.04 0.16→ 0
HRG 674 (467–2,500) 6.6 0.13 18 0.72 0.85→ 1
FOS fructooligosaccharide, RG resistant glucan, HRG hydrogenated resistant glucan, AUC area under the curve. Five grams of test substances were ingested by
healthy subjects. Data were expressed as median and interquartile in 10 healthy subjects. AUCs versus time for 14 h after ingestion of test substance were
calculated based on the date shown in Fig. 5. The available energy of digestable fractions was calculated by content (%) × 4 kcal/g. Available energy was
calculated based on our proposed method [4–6]
a b
Fig. 5 Changes of breath hydrogen excretion after ingestion of RG or HRG in healthy human subjects. FOS, fructooligosaccharide; RG, resistant
glucan; HRG, hydrogenated resistant glucan. Test solution containing 30 g of purified RG or HRG was ingested by 10 healthy subjects shown in
Fig. 4 after overnight fasting, and end-respiratory gas (750 ml) was collected using collection bag at 1-h intervals for 14 h after ingestion (a).
Furthermore, to evaluate the available energy test solution containing 5 g of purified RG or HRG was ingested by healthy subjects after overnight
fasting (b). FOS (5 g) was used as a typical oligosaccharide which is nondigestible and completely fermentable. Figure 5-a shows the change
of hydrogen excretion 14 h after ingestion of 30 g of test substance, and Fig. 5-b shows the change of hydrogen excretion 14 h after ingestion
of 5 g of test substance. Values were means ± SD. *, The excretion of breath hydrogen in RG or HRG ingestion were significantly lower versus
that in FOS ingestion, at P < 0.05 by Steel method. There was no significantly difference between RG and HRG by Steel-Dwass method
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decimal places are not practicable for use in nutrition
education and nutritional labelling, the nearest whole
numbers are used [15, 16]. Therefore, the relative
available energy values were 0 kcal/g for purified RG
and 1 kcal/g for HRG.
Discussion
In the present study we investigated the metabolism and
bioavailability of RG and HRG using rats and healthy
human subjects, thereafter we estimated that the avail-
able energy was 0 kcal/g for purified RG and 1 kcal/g for
HRG in healthy humans, respectively. A small amount
of oligosaccharides in RG and HRG were only digested
and fermented slightly, while a large amount of high
molecular weight carbohydrates were digested scarcely
and fermented barely in healthy humans. These results
demonstrate that the bioavailability of purified RG and
HRG is very low in both humans and rats, although
the response of blood glucose and insulin and the
breath hydrogen excretion are different a little be-
tween rats and humans. Therefore, we discussed first
in terms of rats, and next from the view point of the
bioavailability in humans.
Animal experiments using rats
When purified RG or HRG (400 mg/2.5 ml) was orally
administered to rats, the blood glucose and insulin con-
centrations showed a small but clear peak at 30 min
after administration, although the elevation was clearly
lower than that of glucose administration. Previous ex-
periments have demonstrated that purified RG and HRG
contain a small amount of glucose and a small amount
of oligosaccharides which are hydrolyzed by the small
intestinal enzymes [7]. Therefore, the elevation of blood
glucose level after the administration of purified RG or
HRG seems to depend on a small amount of glucose
and digestible oligosaccharides. Although the contents
of glucose and digestible oligosaccharide were higher in
HRG than in purified RG, the elevation of blood glucose
and insulin was not significantly different between puri-
fied RG and HRG in rats. The blood glucose and insulin
levels might be unable to respond because the amount
of glucose and digestible oligosaccharide in the purified
RG and HRG administered was very little. The blood
glucose level was elevated by the administration of RMD
as well as RG and HRG. RMD also contains a small
amount of glucose and digestible oligosaccharide [10].
Dietary fiber materials that are not natural and have an
average molecular weight of 1500-3000 seem to elevate
slightly blood glucose and insulin levels. Although it has
been recognized that natural dietary fiber materials do
not increase blood glucose and insulin levels, the newly
developed materials which contain a small amount of
glucose and digestible oligosaccharides seems to increase
slightly blood glucose and insulin levels.
Hydrogen is a specific product of fermentation of non-
digestible carbohydrate by intestinal microbes. The
amount of hydrogen excretion fluctuates widely from rat
to rat and among groups, and includes the greater error
at the basal levels. In rats, a small peak of hydrogen ex-
cretion was observed at 2–3 h after administration of
purified RG or HRG and the peak value was greater for
HRG than for purified RG. The results demonstrate that
hydrogen excretion depends on the content of nondiges-
tible oligosaccharides, because nondigestible oligosac-
charides are more abundant in HRG than in purified
RG, from which mono- and di-saccharides have been re-
moved. Furthermore, this suggests that the amount of
nondigestible oligosaccharides is very little compared
with the amount of carbohydrate of high molecular
weight in purified RG and HRG. In contrast, the produc-
tion of hydrogen was maintained for a long time, be-
cause FOS is readily and completely fermented by
intestinal microbes existed abundantly in the gastro-
intestinal tract after the administration of FOS. If high
molecular weight carbohydrates in RG and HRG are fer-
mented spontaneously by intestinal microbes, hydrogen
must be excreted actively as much as FOS and would
not decrease within 6-8 h after administration. These re-
sults suggest that purified RG and HRG contain a small
amount of fermentable oligosaccharides and a large
amount of high molecular weight carbohydrates which
are resistant to fermentation.
Purified RG and HRG are partially hydrolyzed by small
intestinal enzymes and are lightly fermented by intestinal
microbes in rats [7]. In particular, high molecular weight
carbohydrates, which are the main component of RG
and HRG, were hardly hydrolyzed by small intestinal en-
zyme and were scarcely fermented by intestinal microbes.
Therefore, a large proportion of RG and HRG would be
excreted in the feces. However, the recovery for 24 h after
administration to rats was very low. They were 23.4 % for
purified RG and 20.2 % for HRG. One reason for this is
that the perfect recovery of feces is very difficult, because
the stool becomes moistened with urine adhering to the
Metabolica apparatus. Another reason is that a part of
administered RG and HRG may remain in the gastrointes-
tinal tract, because the collection period (24 h) for cecal
and colonic contents and stools might have been too
short. In addition, the extraction of RG and HRG from
stools might not have been complete. However, it could
be confirmed that RG and HRG are excreted into feces.
The results obtained from the experiments using rats
have demonstrated that purified RG, which the content of
dietary fiber is 99 %, is more resistant to digestion and fer-
mentation than HRG, which the content of dietary fiber is
82 %. A part of oligosaccharide fractions, which are the
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minor components of RG and HRG, is digested by small
intestinal enzymes, and other oligosaccharide fractions,
which are not digested by small intestinal enzymes, are
fermented by intestinal microbes. It has also shown that
high molecular weight carbohydrates, which are the main
component of RG and HRG, are difficult to be digested
and fermented.
Human experiments using healthy subjects
The blood glucose and insulin levels increased slightly
but obviously after oral administration of purified RG or
HRG (400 mg) in rats (Fig. 2). However, they increased
scarcely after ingestion of purified RG (30 g) or HRG
(30 g) in the experiments using human participants
(Fig. 4). This discrepancy could be explained partially by
the observation that the hydrolysis of purified RG and
HRG was slightly lower in humans than in rats in the
previous experiments using small intestinal homogenates
[7]. The similar phenomenon, which the hydrolyzing
activity is lower in humans than in rats, has also been
observed for highly cross-linked starch [31]. However,
the hydrolyzing activity for sucrose and maltose, which
are consisted of a simple structure, is similar between
humans and rats [32]. The hydrolyzing activity for car-
bohydrates such as RG and HRG with a unique property
may be different between humans and rats. The re-
sponse of blood glucose and insulin by ingesting RG
and HRG seem to be different in humans when com-
posed to rats. In addition, since the dosage of the test
substance per kg of body weight is calculated as
1333 mg for rats and 545-588 mg for humans, this
difference may have also brought the low response of
blood glucose in humans.
The content of dietary fiber, which is resistant to
hydrolyzing enzymes in AOAC 2001.03 method [8], is
99 % for purified RG and 82 % for HRG. Thus, 1 % of
purified RG and 18 % of HRG are digestible saccharides
producing 4 kcal/g. A part of dietary fiber fraction in
RG and HRG is fermented by intestinal microbes and
hydrogen is produced. In humans, the breath hydro-
gen excretion after HRG ingestion was higher than
that for purified RG, but not statistically significant.
These results demonstrate that HRG contains more
fermentable oligosaccharides compared with purified
RG, although the dietary fiber content is less than
purified RG. But, the excretion of breath hydrogen after
HRG ingestion (30 g) was very low compared with that
after ingesting of fermentable FOS (5 g). In addition, these
results were similar to those observed in rats. If high mo-
lecular weight carbohydrates in RG and HRG are readily
fermented by intestinal microbes, the excretion of breath
hydrogen must be greatly enhanced and maintained the
high level until the end of the experiment as well as FOS.
Moreover, the hydrogen excretion by ingesting RG and
HRG indicates that short chain fatty acids, which are
further metabolized to energy in the host, are produced by
intestinal microbes. Therefore, the available energy which
is brought by the fermentation of RG and HRG is not
0 kcal/g. However, in the present study the available energy
including that of digestible saccharides was evaluated as
0 kcal/g for purified RG and 1 kcal/g for HRG, respectively.
The available energy calculated from fermentation of
nondigestible saccharide and available saccharide was
0.18 kcal/g (0.14 + 0.04 = 0.18) for purified RG, which
the dietary fiber content is 99 %, and was 0.93 kcal/g
(0.21 + 0.72 = 0.93) for HRG, which is more fermentable
than purified RG and the dietary fiber content is 82 %.
The hydrogen excretion showed only a small peak at 3 h
after ingestion of purified RG or HRG (400 mg/2.5 ml)
in rats. But, the pattern of hydrogen excretion after
RMD administration (400 mg/2.5 ml) was clearly differ-
ent from those after administration of RG and HRG. In
other word, the hydrogen excretion of RMD showed a
small shoulder at 3 h and a maximum excretion at 10 h
after administration. Furthermore, in humans a peak of
breath hydrogen is also showed at 6-10 h after ingestion
of RMD as well as rats [5]. The high molecular weight
carbohydrates, which are contained in RMD seem to be
fermented more readily than those in RG and HRG in
rats. Hence, the available energy of RMD, which the
content of digestible oligosaccharides is less than HRG,
is estimated as 1 kcal/g by our proposed method [5] and
other different methods [14].
Extensive intake of nondigestible and/or non-absorbable
mono- or oligo-saccharides such as FOS, 1-kestose, galac-
tosylsucrose, lactulose, trehalose, cellobiose, lactitol, xylitol
and D-tagatose induces essentially loose stool and ab-
dominal symptoms such as thirst, flatus, distension or
borborygmus in rats and humans, and each maximum
non-effective dosage on them are evaluated using
healthy human subjects [25–28, 33–35]. But, natural
dietary fiber materials with high molecular weight do
not cause osmotic loose stool. Abdominal symptoms and
loose stool are influenced by the rate of digestibility and
absorbability, molecular weight and habituation of sugar
substitutes. The maximum non-effective dose of non-
digestible oligosaccharides is 0.3-0.4 g/kg of body weight
[6, 25]. Since RG and HRG contain the small amount of
low molecular weight saccharides which are resistant for
digestion, the extensive intake of them may induce
abdominal symptoms and loose stool. But, none of the
participants experienced loose stools and abdominal
symptoms after ingesting 30 g of purified RG or HRG.
However, two participants experienced light loose stools,
flatus, and borborygmus in the preliminary experiment
after ingesting 50 g of HRG (data not shown). These
results suggest that ingesting 30 g of purified RG and
HRG does not induce side effects in healthy adult.
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On the other hand, FDA (Administration of Drug and
Food) in USA does not decide the maximum non-effective
dose of PD and RMD which are similar characteristics to
RG and HRG and contain much small molecular nondi-
gestible saccharides; in spite of they cause more readily
loose stool than RG and HRG [36]. Side effects such as ab-
dominal symptoms and loose stool may not be important
to dietary fiber ingredient which the intake is much in
quantity under the law. But, the maximum non-effective
dose for abdominal symptoms and loose stool is essential
for design of processed foods. Therefore, it is important
knowledge that the non-effective dose of RG or HRG as
ingredients is more than 30 g, which are not ingested once
in the common living life. However, the ingestion of 30 g
of purified RG and HRG may induce side effects in chil-
dren and aged persons. Further studies are necessary for
children, aged persons and pregnant women.
In previous experiment using rats, the body weight
gain was normal in all groups given the test diet or the
experimental diet, and the blood biochemical parameters
were not significantly different among the control, RG
and HRG groups in consecutive feeding of rats using di-
ets containing purified RG or HRG [7]. Thus, RG and
HRG did not harm the growth and development of rats.
Furthermore, side effects such as loose stool and ab-
dominal symptoms do not appear after ingestion of
RG and HRG (30 g) in healthy adults. In addition,
the abnormality was not detected in acute, subacute
and chronic toxicity tests of RG [1, 9]. Therefore, RG
and HRG can be used aggressively in processed foods
as a dietary fiber supplement.
The indication of energy is an essential item in the nu-
tritional labelling for processed foods. The available en-
ergy of purified RG and HRG was evaluated according
to the indirect and simple method in the present study.
This method has been proposed by the Japanese Society
for Dietary Fiber Research, with the relative available en-
ergy of newly developed dietary fiber and nondigestible
oligosaccharide materials being evaluated using FOS as a
convenient reference [4, 5, 25]. The breath hydrogen ex-
cretion is used as an indicator of extent of fermentation
in the proposed method to evaluate the available energy,
and FOS, which the available energy is 2 kcal/g in prac-
tice, is used as a reference of typical nondigestible and
fermentable oligosaccharide [4, 5]. The expiration to
measure the hydrogen needs to collect for 14 h or longer
after administration of test substances, because some
test materials are slowly fermented by intestinal mi-
crobes in humans [5]. The collection period for more
than 14 h is given more stress for subjects. The available
energy is calculated from the AUC of breath hydrogen
excretion for 14 h against that of FOS.
In this method, 5 g of the test substance was ingested
by healthy participants, and the expiration was collected
to measure the hydrogen excretion for 14 h after inges-
tion. The AUC of breath hydrogen excretion for 14 h
after 5 g ingestion of test substances were 11,740 ppm
for FOS, 850 ppm for purified RG and 1250 ppm for
HRG, respectively. The available energy from fermenta-
tion is calculated as 0.14 kcal/g for purified RG and
0.21 kcal/g for HRG, because the value of FOS, which is
fermented completely by intestinal microbes, is 2 kcal/g.
The content of dietary fiber, which is resistant for hydro-
lyzing enzymes in AOAC 2003.01method, is 99 % for
purified RG and 82 % for HRG, respectively. Since 1 %
of purified RG and 18 % of HRG are digested and con-
verted to energy production, the available energy becomes
0.04 kcal/g for purified RG and 0.72 kcal/g for HRG.
Therefore, total available energy of digestible and nondi-
gestible saccharides becomes to 0.18 (0.14 + 0.04 = 0.18)
kcal/g for purified RG and 0.93 (0.21 + 0.72 = 0.93) kcal/g
for HRG. The practical nearest whole number after round-
ing is 0 kcal/g for purified RG and 1 kcal/g for HRG. The
difference of available energy is dependent on the differ-
ence of dietary fiber content in purified RG and HRG.
Conclusions
The ingestion of purified RG or HRG (30 g) increased
scarcely blood glucose and insulin levels and excreted
slightly hydrogen in healthy human subjects. A small
amount of oligosaccharides in RG and HRG were only
digested and fermented slightly, while a large amount of
high molecular weight carbohydrates were digested
scarcely and fermented barely in healthy humans. There-
fore, the bioavailability of purified RG and HRG was very
low in both humans and rats, although the response of
blood glucose and insulin, and breath hydrogen excre-
tion were slightly different between humans and rats.
Moreover, the ingestion of 30 g of RG or HRG did
not induce any apparent side effects in healthy adults.
Available energy was evaluated as 0 kcal/g for purified
RG and 1 kcal/g for HRG. Therefore, RG and HRG
could be potentially used as new dietary fiber mate-
rials with low energy.
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